These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4429641)

  • 1. Stabilization of soluble fibrin-fibrinogen complexes by fibrin stabilizing factor (FSF).
    Ly B; Kierulf P; Jakobsen E
    Thromb Res; 1974 Apr; 4(4):509-22. PubMed ID: 4429641
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporation of fibrinogen into soluble fibrin complexes.
    Jakobsen E; Ly B; Kierulf P
    Thromb Res; 1974 Apr; 4(4):499-507. PubMed ID: 4428463
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of soluble, FSF-stabilized fibrin complexes with special reference to the role of fibrinogen.
    Ly B; Kierulf P; Jakobsen E; Gravem K
    Thromb Res; 1974 Jul; 5(1):21-32. PubMed ID: 4428469
    [No Abstract]   [Full Text] [Related]  

  • 4. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different chromatographic behaviour of soluble, non-FSF-stabilized des-AA fibrin/fibrinogen and des-AABB fibrin/fibrinogen complexes.
    Brosstad F
    Thromb Res; 1979; 15(3-4):563-8. PubMed ID: 40318
    [No Abstract]   [Full Text] [Related]  

  • 6. Human fibrinogen free of factor XIII: the pursuit of biological zero.
    Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():149-54. PubMed ID: 4629549
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of human plasma fibrin stabilizing factor (factor XIII) from fibrinogen by fibrinogen polymer formation.
    Becker CM
    Biochem Biophys Res Commun; 1986 Jan; 134(2):678-84. PubMed ID: 3947344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS; Achyuthan KE; Miraglia CC; Dobson JV
    Ann N Y Acad Sci; 1986; 485():140-3. PubMed ID: 3471145
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-linking of salmon fibrinogen and fibrin by factor XIII and transglutaminase.
    Murtaugh PA; Halver JE; Gladner JA
    Biochem Biophys Res Commun; 1973 Oct; 54(3):849-55. PubMed ID: 4148128
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble fibrin monomer complexes demonstrated by agarose gel filtration and by adsorption on insolubilized fibrinogen: a comparative study.
    von Hugo R; Stemberger A; Graeff H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):216-22. PubMed ID: 1188711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S; Markiewicz M; Nath N
    J Lab Clin Med; 1973 May; 81(5):641-50. PubMed ID: 4698655
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-linking of actin and fibrin by fibrin-stabilizing factor.
    Mui PT; Ganguly P
    Am J Physiol; 1977 Sep; 233(3):H346-9. PubMed ID: 910923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
    Lorand L
    Ann N Y Acad Sci; 2001; 936():291-311. PubMed ID: 11460485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.